|
Volumn 39, Issue 8, 2012, Pages 738-739
|
Cutaneous polyarteritis nodosa induced by Mycobacterium tuberculosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMPLEMENT COMPONENT C3;
COMPLEMENT COMPONENT C4;
ETHAMBUTOL;
ISONIAZID;
LOXOPROFEN;
MYELOBLASTIN;
MYELOPEROXIDASE;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
PYRAZINAMIDE;
RIFAMPICIN;
SOLUBLE INTERLEUKIN 2 RECEPTOR;
AXILLA;
CELL INFILTRATION;
COMPUTER ASSISTED TOMOGRAPHY;
CONSULTATION;
CUTANEOUS POLYARTERITIS NODOSA;
DIFFERENTIAL DIAGNOSIS;
DRUG EFFICACY;
ENTERITIS;
HEPATITIS B VIRUS;
HISTOPATHOLOGY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN PARVOVIRUS B19;
INFLAMMATORY CELL;
LETTER;
LEUKOCYTE COUNT;
LYMPHADENOPATHY;
MYCOBACTERIUM TUBERCULOSIS;
PHYSICAL EXAMINATION;
POLYARTERITIS NODOSA;
SKIN BIOPSY;
SPUTUM CULTURE;
STREPTOCOCCUS GROUP A;
SUBCUTANEOUS TISSUE;
THORAX RADIOGRAPHY;
THROMBUS;
TREATMENT DURATION;
TUBERCULOSIS;
ULCER;
ANTITUBERCULAR AGENTS;
DRUG THERAPY, COMBINATION;
ETHAMBUTOL;
HUMANS;
ISONIAZID;
LUNG;
MALE;
MIDDLE AGED;
MYCOBACTERIUM TUBERCULOSIS;
PHENYLPROPIONATES;
POLYARTERITIS NODOSA;
PYRAZINAMIDE;
RIFAMPIN;
TREATMENT OUTCOME;
TUBERCULOSIS, CUTANEOUS;
|
EID: 84864416464
PISSN: 03852407
EISSN: 13468138
Source Type: Journal
DOI: 10.1111/j.1346-8138.2011.01398.x Document Type: Letter |
Times cited : (13)
|
References (5)
|